WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Stock Ownership - Who owns Kura Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kura Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Troy Edward WilsonPresident and CEO2025-09-2936,615$8.94
$327.41kSell
Teresa Brophy BairChief Legal Officer2025-09-298,805$8.94
$78.73kSell
Thomas James DoyleSVP Finance Accounting2025-09-294,541$8.94
$40.61kSell
Kathleen FordChief Operating Officer2025-09-296,892$8.94
$61.63kSell
Mollie LeoniChief Medical Officer2025-09-2912,314$8.94
$110.11kSell
Brian T. PowlChief Commercial Officer2025-09-298,891$8.94
$79.50kSell
Troy Edward WilsonPresident CEO2025-09-0850,000$8.20
$410.15kBuy
Troy Edward WilsonPresident and CEO2025-08-1313,494$6.64
$89.63kBuy
Troy Edward WilsonPresident and CEO2025-08-1236,506$5.85
$213.60kBuy
Kathleen FordChief Operating Officer2025-05-191,558$6.28
$9.78kSell

1 of 3

KURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KURA insiders and whales buy or sell their stock.

KURA Shareholders

What type of owners hold Kura Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.94%9,470,333$93.19MInstitution
Suvretta Capital Management LLC9.37%8,116,000$79.86MInstitution
Bvf Inc8.96%7,754,129$76.30MInstitution
Armistice Capital LLC7.16%6,200,000$61.01MInstitution
Vanguard Group Inc6.18%5,348,325$52.63MInstitution
Ecor1 Capital Fund Qualified LP5.09%4,408,097$43.38MInsider
Ecor1 Capital LLC4.85%4,200,000$41.33MInstitution
Prosight Management LP3.67%3,181,184$31.30MInstitution
State Street Corp3.51%3,036,858$29.88MInstitution
Millennium Management LLC3.03%2,621,522$25.80MInstitution

1 of 3

KURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KURA90.43%9.57%Net SellingNet Buying
GHRS70.22%0.00%
PVLA48.78%51.22%Net Buying
VIR67.58%32.42%Net SellingNet Selling
ABUS29.81%70.19%Net Selling
View Top Biotech Stocks

Kura Oncology Stock Ownership FAQ

Who owns Kura Oncology?

Kura Oncology (NASDAQ: KURA) is owned by 94.90% institutional shareholders, 10.05% Kura Oncology insiders, and 0.00% retail investors. Ecor1 Capital Fund Qualified LP is the largest individual Kura Oncology shareholder, owning 4.41M shares representing 5.09% of the company. Ecor1 Capital Fund Qualified LP's Kura Oncology shares are currently valued at $44.04M.

If you're new to stock investing, here's how to buy Kura Oncology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.